Establishment of the multidisciplinary Committee for Control and Prevention of Infections as key factor for the rationalization of antibiotic utilization in Clinical Hospital Acibadem Sistina-Skopje

Author:

Buhov Dragana1,Naumovska Zorica2,Suturkova Ljubica2

Affiliation:

1. Clinical Hospital Acibadem Sistina-Skopje, Skupi 5A, 1000 Skopje, R. N. Macedonia

2. Institute of Pharmaceutical Chemistry, Faculty of Pharmacy, Ss. Cyril and Methodius University, Mother Theresa 47, 1000 Skopje, R. N. Macedonia

Abstract

Antibiotics are indicated in the prevention and treatment of bacterial infections. Antibiotic resistance is a global healthcare problem, strongly connected to hospital-acquired infections. As drug resistance is world-wild problem new educational programs and prescribing and utilization strategies should be developed. Evaluation of the implementation of the measures by Committee for control and prevention of infections at Clinical Hospital Acibadem Sistina-Skopje and assessment of its function in the monitoring of the level of infections and rationalization in antibiotics prescription in hospitalized patients. Isolates taken from patients in the Clinical Hospital Acibadem Sistina-Skopje were used in this study. Monthly and annual analysis was performed by pharmacist for a controlled group of antibiotics prescribed based on obtained antibiogram results confirmed by a microbiologist.The Committee for Control and Prevention of Infections also monitors the consumption of antibiotics on a monthly and annual basis calculated through the list of published antibiotics in defined daily doses (DDD-Defined daily doses) per 1000 hospital days. Obtained results present that consumption of controlled antibiotics is stable in the evaluated period with a tendency of declination. They are used in indicated patients with the exception of Imipenem/Cilastatin. The evaluation of previously applied to proscribe routine for this combined antibiotic suggested that the patients were sub-dosed. The applied measure resulted in rational and appropriate dosing of the patients and coherent increased consumption of Imipenem/Cilastatin. The second measure applied was associated with the rationalization of surgical profilaxis and substitution of ceftriaxone with cefazolin. The costs in 2016 were 12 421 100 MKD (201 969 Eur), compared to the expenditures in 2017 of 11 891 000 MKD. (193 349 Eur). Implementation of appropriate measures by establishment of the Committee led to the reduction of irrational antibiotics utilization and decrease of the antibiotics associated expenditure in the Clinical Hospital Acibadem Sistina. Keywords: antibiotics, antibiotic resistance, rational antibiotic utilization, expenditures

Publisher

Macedonian Pharmaceutical Association

Subject

General Medicine

Reference10 articles.

1. Milori, A., Migliori, E., 2017. Antibiotic Resistance and Infection Control: Physicians Aspects and Beliefs. J. Antimicrob. Agents 3(2), 1-3. Available at: https://doi.org/10.4172/2472-1212.100013.

2. National Institute of Allergy and Infectious Diseases.Antimicrobial Drug Resistance, 2016. 5-13. Available at: https://www.niaid.nih.gov/research/antimicrobial-resistance.

3. Rizi, K.S., Ghazvini, K., Noghondar, M.K., 2018. Adaptive Antibiotic Resistance: Overview and Perspectives - Department of Microbiology and Virology, J. Infect. Dis. Ther. 6(3), 1-4. Available at: https://doi.org/10.4172/2332-0877.1000363.

4. United Nations, 2018. Consumption of antibiotics in Serbia reduces by 38,2%. Available at: https://serbia.un.org/11820-consumption-antibiotics-serbia-reduced-382.

5. U.S. National Library of Medicine, 2018. About Bacteria and Antibiotics , 1-3. Available at: https://medlineplus.gov/antibiotics.html#summar.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3